Puma Biotechnology
PBYI
#8375
Rank
ยฃ0.11 B
Marketcap
ยฃ2.38
Share price
3.45%
Change (1 day)
-28.08%
Change (1 year)

P/E ratio for Puma Biotechnology (PBYI)

P/E ratio as of November 2024 (TTM): -62.6

According to Puma Biotechnology's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -62.6. At the end of 2022 the company had a P/E ratio of > 1000.

P/E ratio history for Puma Biotechnology from 2012 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022> 1000-7.1187688215167E+18%
2021-4.28-36.98%
2020-6.7952.2%
2019-4.46-34.41%
2018-6.81-45.95%
2017-12.6240.44%
2016-3.70-64.9%
2015-10.5-73.72%
2014-40.1-26.41%
2013-54.5902.61%
2012-5.43

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.